Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.
Belli LS, Volpes R, Graziadei I, Fagiuoli S, Starkel P, Burra P, Alberti AB, Gridelli B, Vogel W, Pasulo L, De Martin E, Guido M, De Carlis L, Lerut J, Cillo U, Burroughs AK, Pinzello G. Belli LS, et al. Among authors: lerut j. Dig Liver Dis. 2012 Jul;44(7):603-9. doi: 10.1016/j.dld.2012.01.017. Epub 2012 Mar 15. Dig Liver Dis. 2012. PMID: 22424641 Clinical Trial.
Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation.
Mazzaferro V, Regalia E, Montalto F, Pulvirenti A, Brunetto MR, Bonino F, Lerut J, Gennari L. Mazzaferro V, et al. Among authors: lerut j. Liver. 1996 Apr;16(2):117-22. doi: 10.1111/j.1600-0676.1996.tb00715.x. Liver. 1996. PMID: 8740845
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.
Féray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, Loinaz C, Gigou M, Burra P, Barkholt L, Esteban R, Bizollon T, Lerut J, Minello-Franza A, Bernard PH, Nachbaur K, Botta-Fridlund D, Bismuth H, Schalm SW, Samuel D. Féray C, et al. Among authors: lerut j. Gastroenterology. 1999 Sep;117(3):619-25. doi: 10.1016/s0016-5085(99)70454-3. Gastroenterology. 1999. PMID: 10464137
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.
Adler M, De Pauw F, Vereerstraeten P, Fancello A, Lerut J, Starkel P, Van Vlierberghe H, Troisi R, Donckier V, Detry O, Delwaide J, Michielsen P, Chapelle T, Pirenne J, Nevens F. Adler M, et al. Among authors: lerut j. Liver Transpl. 2008 Apr;14(4):526-33. doi: 10.1002/lt.21399. Liver Transpl. 2008. PMID: 18383082 Free article.
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group. Mazzaferro V, et al. Among authors: lerut j. Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5. Epub 2008 Dec 4. Lancet Oncol. 2009. PMID: 19058754
390 results